018567547
Lymphogrow
September 27, 2021
Trademark Summary
The trademark Lymphogrow was filed by Serana Europe GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on October 25, 2021, and received one opposition filed on January 24, 2022 by CYTOGEN Produkte für Medizin + Forschung GmbH on (a) Art. 8(4), (b) Identity of marks and Goods and Services, (c) Likelihood of confusion. the opponent was represented by RDP RÖHL - DEHM & PARTNER and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 24, 2022
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
- The mark was filed in class 1 with following description of goods:
- Cytogenic media for industrial use
- Cytogenic media for scientific use
- Cytogenic media for technical use.
- The mark was filed in class 5 with following description of goods:
- Cytogenic media for medical use
- Cytogenic media for veterinary use
- Cytogenic media for pharmaceutical use.
